Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05183763 · ClinicalTrials.gov registry record · NA

Medication Adherence Program

A NA study of Hypertension and Medication Adherence, sponsored by Tulane University.

Recruiting
Registry status
NA
Development phase
402
Enrollment target
5
Study locations

NCT05183763 is a NA study of Hypertension and Medication Adherence that is actively recruiting participants, run by Tulane University. The registered enrollment target is 402 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The trial reports 5 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05183763, a NA study of Hypertension and Medication Adherence, is actively recruiting participants, sponsored by Tulane University.

RECRUITING
Registry status
NA
Development phase
402 participants
Enrollment target
5
Study locations

Study Summary

Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants (n=402) \>=40 years old with a diagnosis of hypertension, uncontrolled blood pressure, and low antihypertensive medication adherence will be recruited through a statewide health insurer, Blue Cross Blue Shield of Louisiana, and randomized to receive either interactive health coaching sessions with medication reminder tools (intervention) or medication reminder tools only (control) over one year. Data will be collected from participants at baseline, 6 months, 12 months, and 24 months using questionnaires, physical measurement (height, weight, blood pressure), a computer-based single-category implicit association test, and laboratory analysis of antihypertensive medication urinary metabolites.

Interventions

  • BEHAVIORAL STAR-MAP health coaching
  • BEHAVIORAL Medication reminder tools

Study Locations (5)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge
  • Tulane Doctors Dermatology & Multispecialty Clinic - Covington
  • Tulane Doctors Heart & Vascular and Primary Care Clinic - Metairie
  • Tulane University Clinical and Translational Unit - New Orleans
  • LSU Health Sciences Shreveport Clinical Trials Office - Shreveport

Trial Details

FieldValue
Enrollment Target 402 participants
Start Date 2022-03-07
Est. Completion 2027-04-30
Phase NA

Sponsor

Tulane University

73 total trials

What the Registry Record Tells You About NCT05183763

The ClinicalTrials.gov registry entry for NCT05183763 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (89% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which STAR-MAP health coaching is the first listed.

NCT05183763 reports 5 study locations spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05183763 about?

NCT05183763 is a clinical study titled "Medication Adherence Program". Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants ...

What is the current status of trial NCT05183763?

This trial is currently recruiting. It is a NA study. The enrollment target is 402 participants. The study started on 2022-03-07. Estimated completion is 2027-04-30.

What conditions does trial NCT05183763 study?

This clinical trial studies the following conditions: Hypertension, Medication Adherence, Behavior and Behavior Mechanisms.

What interventions are being tested in trial NCT05183763?

The interventions under investigation include: STAR-MAP health coaching (BEHAVIORAL), Medication reminder tools (BEHAVIORAL).

Who is sponsoring clinical trial NCT05183763?

This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05183763 being conducted?

This trial has 5 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.